Steven Cohen’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$100K Hold
10,806
– – ﹤0.01% 3653
2026
Q2
$166K Buy
+10,806
New +$133K ﹤0.01% 3587
2023
Q2
– Sell
-71,466
Closed -$1.06M – 2455
2023
Q1
$1.06M Hold
71,466
– – ﹤0.01% 1096
2022
Q4
$1M Sell
71,466
-61,034
-46% -$1.66M ﹤0.01% 1049
2022
Q3
$4.19M Hold
132,500
– – 0.02% 770
2022
Q2
$4.6M Buy
132,500
+60,000
+83% +$3.84M 0.02% 730
2022
Q1
$8.19M Hold
72,500
– – 0.03% 569
2021
Q4
$6.94M Buy
72,500
+10,000
+16% +$901K 0.03% 603
2021
Q3
$5.53M Buy
+62,500
New +$6.15M 0.02% 640
2021
Q2
– Sell
-43,305
Closed -$6.9M – 1062
2021
Q1
$6.9M Buy
43,305
+22,855
+112% +$3.88M 0.03% 515
2020
Q4
$3.13M Buy
+20,450
New +$3.67M 0.02% 662
2020
Q3
– Sell
-17,500
Closed -$2.12M – 999
2020
Q2
$2.12M Buy
+17,500
New +$1.78M 0.01% 582

Other funds holding IMUX

Steven Cohen's IMUX Position: Q3 2026 in Review

Steven Cohen held its Immunic (IMUX) position steady in Q3 2026 at 10,806 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3653.

Steven Cohen first reported a position in IMUX in Q2 2020 and has held it in 12 quarters since. The position peaked at $8.19M in Q1 2022. 79 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • Steven Cohen held 10,806 shares of Immunic worth $100K as of Q3 2026.
  • Steven Cohen left its Immunic share count unchanged in Q3 2026.
  • Immunic made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3653 holding.
  • Steven Cohen first reported a position in Immunic in Q2 2020 and has held it in 12 quarters since.
  • Steven Cohen's Immunic position peaked at $8.19M in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.